Harrow Health, Inc. Common Stock

Go to Harrow Health, Inc. Common Stock Website

$33.45

0.03 (0.09%)
Live
Previous Close

$33.42

Day Range

$32.64 - $33.895

Previous Day Range

$31.24 - $33.47

Market Cap

$1.1 billion USD

Day Vol.

296879

Previous Day Vol.

431959

Currency

USD

Primary Exchange

Nasdaq

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making ...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Pomerantz LLP is investigating potential securities fraud at Harrow, Inc. after the company missed financial estimates in Q1 2025, causing its stock price to drop 4.07%.

Related tickers: HROW, HROWL, HROWM.

Read Full Article

Nicox announced that the last patient has completed the final visit in the Whistler Phase 3b clinical trial for its lead product candidate NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The results of the Denali Phase 3 trial are also expected in Q3 2025.

Related tickers: BLCO, HROW, HROWL, HROWM.

Read Full Article
Trending Tickers

Please sign in to view